abbv-382
Showing 1 - 2 of 2
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
Human Immunodeficiency Virus (HIV) Trial in Puerto Rico, United States (ABBV-382, Placebo for ABBV-382)
Recruiting
- Human Immunodeficiency Virus (HIV)
- ABBV-382
- Placebo for ABBV-382
-
Bakersfield, California
- +20 more
Dec 15, 2022